Enovis Corp. (ENOV)
22.73
+0.43
(+1.93%)
USD |
NYSE |
Feb 20, 16:00
22.73
0.00 (0.00%)
After-Hours: 20:00
Enovis SG&A Expense (Quarterly) : 263.62M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Twist Bioscience Corp. | 69.74M |
| Abbott Laboratories | 3.129B |
| Accuray, Inc. | 18.91M |
| Alphatec Holdings, Inc. | 124.30M |
| Plus Therapeutics, Inc. | 3.443M |